Clinical trials
Completed Observational Shock trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
118 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 9 |
| 2013 | 4 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 118 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de Nīmes | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| University Medical Center Groningen | 3 |
| University of Pennsylvania | 3 |
| University of Ulm | 3 |
| Avicenna Military Hospital | 2 |
| Beth Israel Deaconess Medical Center | 2 |
| Bicetre Hospital | 2 |
| Brighton and Sussex University Hospitals NHS Trust | 2 |
| Catharina Ziekenhuis Eindhoven | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock | 118 |
| Critical Illness | 15 |
| Sepsis | 12 |
| Hypotension | 9 |
| Acute Kidney Injury | 7 |
| Emergencies | 7 |
| Heart Failure | 7 |
| Inflammation | 7 |
| Wounds and Injuries | 7 |
| Infections | 6 |
Trials
Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.
18 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.